ArticleFood and waterborne parasitology2022
Validation of a multilocus genotyping scheme for subtyping
Article in Food and waterborne parasitology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
25 citing papers in PubMed.
- Addition of multi-locus variable number tandem repeat analysis to assistFood and waterborne parasitology · 2026Article
- High resolution multi-locus sequence typing scheme for Giardia duodenalis assemblage B outbreak and population analysis.PLoS neglected tropical diseases · 2026Article
- Large-scale molecular epidemiological survey ofJournal of clinical microbiology · 2026Article
- Cryptosporidium parvum and bovine coronavirus in naturally and experimentally exposed calves: clinical outcome and pathogen shedding.Veterinary research · 2026Article
- Advancing genomics for waterborne pathogen surveillance in Australia.The Lancet regional health. Western Pacific · 2026Review
- Population structure and zoonotic potential of Cryptosporidium parvum in Italy inferred using a multi-locus sequence typing scheme.Parasites & vectors · 2026Article
- A Multilocus Variable-Number Tandem-Repeat Analysis (MLVA) Scheme for Epidemiological Investigations of Cryptosporidium parvum.Methods in molecular biology (Clifton, N.J.) · 2026Article
- The transformation of aFood and waterborne parasitology · 2025Review
- ConcurrentEuro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin · 2025Article
- Multilocus Variable-Number Tandem-Repeat Analysis as an Investigation Tool inMicroorganisms · 2025Article
- Article
- Article
- Design, development, and testing of a new multi-locus sequence typing scheme for the zoonotic pathogenCurrent research in parasitology & vector-borne diseases · 2025Article
- Investigating genetic diversity withinCurrent research in parasitology & vector-borne diseases · 2025Article
- Parapipe: a pipeline for parasite next-generation sequencing data analysis applied to Cryptosporidium.Access microbiology · 2025Article
- Molecular Detection and Characterization of Cryptosporidium spp. and Giardia duodenalis in Dairy Calves from Ningxia, China.Acta parasitologica · 2024Article
- A large cryptosporidiosis outbreak associated with an animal contact event in England: a retrospective cohort study, 2023.Epidemiology and infection · 2024Article
- Genetic characterisation ofCurrent research in parasitology & vector-borne diseases · 2024Article
- Preliminary investigation of a significant nationalEuro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin · 2023Article
- First identification of Cryptosporidium parvum virus 1 (CSpV1) in various subtypes of Cryptosporidium parvum from diarrheic calves, lambs and goat kids from France.Veterinary research · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Subtyping
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.